LOGILIA Drug Patent Profile
✉ Email this page to a colleague
When do Logilia patents expire, and what generic alternatives are available?
Logilia is a drug marketed by Teva Pharms Usa and is included in one NDA.
The generic ingredient in LOGILIA is ulipristal acetate. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the ulipristal acetate profile page.
US Patents and Regulatory Information for LOGILIA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharms Usa | LOGILIA | ulipristal acetate | TABLET;ORAL | 207952-001 | Feb 13, 2017 | AB | RX | No | No | ⤷ Get Started Free | ⤷ Get Started Free | ⤷ Get Started Free | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
